Form 4 for RGNX REGENXBIO Inc.
Accepted 2025-07-03 00:00:00 ET · period of report 2025-07-01 · accession 0001562180-25-005334 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-03 | 2025-07-01 | RGNX | Simpson Curran | CEO, Dir | F - Tax | $8.23 | -4,701 | 252.3K | -2% | -$38.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-01 | F | D | 4,701 | $8.23 | 252,331 | D | — | — | (F1) Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on July 1, 2024. The number of shares withheld was determined based on the closing price of the issuer's common stock on July 1, 2025. |